ISTH 2022 Congress
COVID and Coagulation
Theme Navigation
- ISTH 2022 Congress
- COVID and Coagulation
-
Abstract Number: VPB0607
A Comparison of eNOS-based Platelet Subpopulation Ratios and Platelet VEGF Content within COVID-19
-
Abstract Number: PO0012
A frequency of anti-PF4/heparin antibodies and LA in patients with COVID-19
-
Abstract Number: PB0051
A Multicenter Cohort Study of COVID-19 Associated Venous Thromboembolism in Admitted Patients Followed Longitudinally 3-Months After Discharge
-
Abstract Number: OC 13.5
A Multicenter Randomized Clinical Trial of Modulation of Host Thromboinflammatory Response in Hospitalized Patients with COVID-19: The DAWn-Antico study
-
Abstract Number: VPB0141
A near real-time surveillance algorithm to identify in-hospital VITT cases
-
Abstract Number: PB0045
A pilot, open-label, phase II clinical trial of nebulised recombinant tissue-plasminogen activator in patients with COVID-19 acute respiratory distress syndrome: the PACA trial
-
Abstract Number: PB0054
A role for Von Willebrand Factor-ADAMTS13 axis imbalance and abnormal angiogenesis in Long COVID syndrome
-
Abstract Number: PB0604
Abridging Molecular System Network of COVID-19 and Thrombosis
-
Abstract Number: OC 33.3
Absence of Hypercoagulability after nCoV-19 Vaccination: an observational longitudinal study
-
Abstract Number: PB0600
ADAMTS13 activity and non-parallel vWF Ristocetin CoFactor activity are associated with severity of COVID-19 infection
-
Abstract Number: PB0091
ADAMTS13 in the diagnosis of the severity of COVID-19 mortality
-
Abstract Number: VPB0611
Alteration of circulating ACE2 regulating microRNAs profiles in patients with COVID-19
-
Abstract Number: VPB0130
Alterations in the coagulation profile and mortality due to covid-19 during the first and second wave in peruvians: A retrospective cohort in a national reference center.
-
Abstract Number: PB0592
Altered Fibrin Network Structure and Fibrinolysis in Intensive Care Unit Patients with COVID-19, Not Entirely Explaining the Increased Risk of Thrombosis
-
Abstract Number: VPB0612
Angiostatin and Plasminogen Levels as Risk Factors for Mortality in Hospitalized Covid-19 Patients
-
Abstract Number: OC 33.5
Anti-PF4 IgG levels in patients with VITT remain high at 7 months following vaccination and can still activate platelets
-
Abstract Number: PB0596
Anti-SARS-CoV-2 vaccines do not induce a hypercoagulable state in healthy individuals
-
Abstract Number: PB0076
Antiphospholipid antibodies in patients with acute ischaemic stroke during the COVID-19 pandemic
- 1
- 2
- 3
- …
- 9
- Next Page »